Home / Resource Library / A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL

A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL

Results of a study examining ibrutinib with venetoclax for treatment of CLL.